A61P 25 - Drugs for disorders of the nervous system

Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
11/1997
11/06/1997	WO1997041096A1 New vitamin d derivatives with carbo- or heterocyclic substituents at c-25, a process for their production, intermediate products and their use for producing medicaments
11/06/1997	WO1997040680A1 Antioxidant compound
11/06/1997	CA2253288A1 New vitamin d derivatives with carbo- or heterocyclic substituents at c-25, process for their production, intermediate products and use for the production of pharmaceutical agents
11/06/1997	CA2253259A1 Processed polypeptides with il-16 activity, process for preparing the same and their use
11/06/1997	CA2252696A1 Azetidinone derivatives for the treatment of atherosclerosis
11/05/1997	EP0805158A2 Halo-substituted protein kinase C inhibitors
11/05/1997	EP0805153A1 Novel muscarinic receptor agonists
11/05/1997	EP0805147A1 Novel N-substituted alpha aminoacid amides as calcium channel modulators
11/05/1997	EP0804615A1 Apolipoprotein e polymorphism and treatment of alzheimer's disease
11/05/1997	EP0804613A1 Tumor suppressor genes, proteins encoded thereby and use of said genes and proteins
11/05/1997	EP0804602A1 Hsv viral vector
11/05/1997	EP0804601A1 Genetic therapy of tumours with an endothelium cell-specific active substance which is dependent on the cell cycle
11/05/1997	EP0804574A1 Human kappa opioid receptor, nucleic acids and uses thereof
11/05/1997	EP0804564A1 Neural axon outgrowth modulators
11/05/1997	EP0804469A1 Novel peptide
11/05/1997	EP0804463A1 Neurokinine (tachykinine) antagonists
11/05/1997	EP0804459A1 Therapeutic compound - fatty acid conjugates
11/05/1997	EP0804440A1 Tricyclic benzazepine vasopressin antagonists
11/05/1997	EP0804437A1 [a]-ANNELATED PYRROLE DERIVATIVES AND PHARMACEUTICAL USES THEREOF
11/05/1997	EP0804434A1 Azetidine, pyrrolidine and piperidine derivatives
11/05/1997	EP0804425A2 Benzodiazepine derivatives
11/05/1997	EP0804419A1 Quinoline derivatives as tachykinin nk 3 receptor antagonists
11/05/1997	EP0804416A1 Heterocyclic compounds, useful as allosteric effectors at muscarinic receptors
11/05/1997	EP0804239A1 Anti-stress, anti-impairment and anti-aging drug and process for manufacturing thereof
11/05/1997	EP0804228A1 The use of activated protein c for preparing a pharmaceutical preparation
11/05/1997	EP0804226A1 Human choline acetyltransferase
11/05/1997	EP0804199A1 Use of penciclorin for the treatment of post-therapeutic neuralgia
11/05/1997	EP0804196A1 Use of serotonin antagonists (5ht 3?) for treating fibromyalgia
11/05/1997	EP0804192A1 Pharmaceutical preparations for tumour necrosis factor (tnf) inhibition
11/05/1997	EP0804186A1 Indole diterpene alkaloid compounds
11/05/1997	EP0804185A1 Arsenic medicaments for the treatment of chronic fatigue syndrome
11/05/1997	EP0804182A2 Use of gabapentin in the treatment of anxiety and panic
11/05/1997	EP0804179A2 Use of n-acyl derivatives of aminoalcohols in the manufacture of a medicament for practising neuroprotective action in neuropathological states connected with excitotoxicity
11/05/1997	EP0724584B1 Heterocyclic amines having central nervous system activity
11/05/1997	EP0544756B1 1,2,5,6-tetrahydro-1-methylpyridines, their preparation and use
11/05/1997	CN1164234A Pyrrolo £2,3-d\| pyrimidines and their use
11/05/1997	CN1163893A Process improvement in synthesis of N-£3-(3-cyanopyrazolo£1,5-alpha\| pyrimidin-7-yl) phenyli-N-ethyl-acetamide
11/05/1997	CN1163884A Dimethyl-(3-aryl-but-3-enyl)-amine compounds as pharmaceutical active ingredients
11/04/1997	US5684204 Sulfur containing di-tert-butylphenol compounds useful as anti-inflammatory agents
11/04/1997	US5684160 3-aminopyrroles, methods for their synthesis and for their pharmaceutical use
11/04/1997	US5684133 Neurite growth regulatory factors, antibodies thereto, and pharmaceutical compositions
11/04/1997	US5684033 Antiarthritic agents, analgesics and migraine
11/04/1997	US5684031 Dihydrobenzofuran and related compounds useful as anti-inflammatory agents
11/04/1997	US5684021 Aminoalkyloximes for treating depression and affective disorders
11/04/1997	US5684020 Piperazine, piperidine and 1,2,5,6-tetrahydropyridine
11/04/1997	US5684015 Angiotensin antagonist as hypotensive agents and cardiovascular disorders
11/04/1997	US5684012 Dimeric piperidine, tetrahydropyridine and piperazine derivatives
11/04/1997	US5684005 Phenylpyrimidine compounds as inhibitors of excitatory amino acid glutamate
11/04/1997	US5684002 Dihydorbenzofuran and related compounds useful as anti-inflammatory agents
11/04/1997	US5683151 Hydraulic unit for traction-controlled motor vehicle brake systems
11/04/1997	CA2083698C (+)-alpha-(2,3-dimethoxyphenyl)-1- [2-(4-fluorophenyl) ethyl]-4-piperidinemethanol
11/04/1997	CA2025413C S-triazolo¬3,4-i\|purine derivatives
11/03/1997	CA2204082A1 Pharmaceutical compounds
10/1997
10/30/1997	WO1997040158A1 Epimorphin antagonist and process for producing the same
10/30/1997	WO1997040152A1 Glial cell line-derived neurotrophic factor receptor
10/30/1997	WO1997040071A1 Compounds with growth hormone releasing properties
10/30/1997	WO1997040070A1 Conjugates of lipophilic moieties and fragments of vasoactive intestinal peptide (vip)
10/30/1997	WO1997040066A1 Suppression of immune response via inhibition of cathepsin s
10/30/1997	WO1997040064A1 Human netrin-1
10/30/1997	WO1997040045A1 Heterocyclic compounds and their preparation and use
10/30/1997	WO1997040044A1 Heterocyclic compounds
10/30/1997	WO1997040043A1 Heterocyclic compounds
10/30/1997	WO1997040042A1 Heterocyclic compounds
10/30/1997	WO1997040038A1 Piperidines and pyrrolidines
10/30/1997	WO1997040032A1 Chiral phenyldihydrofuranones as pde-iv inhibitors
10/30/1997	WO1997040027A1 Substituted benzylamines and their use for the treatment of depression
10/30/1997	WO1997040017A2 Modulators of molecules with phosphotyrosine recognition units
10/30/1997	WO1997040016A1 Heterocyclic compounds
10/30/1997	WO1997040015A1 Tricyclic aminoalkylcarboxamides; novel dopamine d3 receptor subtype specific ligands
10/30/1997	WO1997040012A1 Pyridinyl-2-cyclopenten-1-ones as selective cyclooxygenase-2 inhibitors
10/30/1997	WO1997040011A1 Pharmaceutical compositions for prevention and treatment of central nervous system disorders
10/30/1997	WO1997039756A1 Use of phosphonic acid esters for the treatment of functional disorders of the brain and depression
10/30/1997	WO1997039753A1 Heterocyclic compounds
10/30/1997	WO1997034567A3 Method for treating huntington's disease using glial cell line-derived neurotrophic factor (gdnf) protein product
10/30/1997	WO1997006255A3 Mammalian apoptosis inhibitor protein gene family, primers, probes and detection methods
10/30/1997	DE19617864A1 Neue chirale Phenyldihydrofuranone New chiral Phenyldihydrofuranone
10/30/1997	DE19616471A1 Phosponsäureester zur Behandlung von Hirnleistungsstörungen und Depressionen Phosponsäureester for the treatment of brain disorders and depression
10/30/1997	CA2252573A1 Heterocyclic compounds
10/30/1997	CA2252567A1 Use of phosphonic acid esters for the treatment of functional disorders of the brain and depression
10/30/1997	CA2252563A1 Heterocyclic compounds and their preparation and use
10/30/1997	CA2252527A1 Heterocyclic compounds
10/30/1997	CA2252458A1 Conjugates of lipophilic moieties and fragments of vasoactive intestinal peptide (vip)
10/30/1997	CA2252385A1 Piperidines and pyrrolidines
10/30/1997	CA2251989A1 Tricyclic aminoalkylcarboxamides; novel dopamine d3 receptor subtype specific ligands
10/30/1997	CA2251974A1 Heterocyclic compounds
10/30/1997	CA2251714A1 Suppression of immune response via inhibition of cathepsin s
10/30/1997	CA2250873A1 Heterocyclic compounds
10/30/1997	CA2250472A1 Heterocyclic compounds
10/29/1997	EP0803501A1 Substituted guanidine derivatives and their use as Na+/H+ exchange inhibitors
10/29/1997	EP0803253A1 Matrix-type oral sustained-release tablets containing tianeptine sodium salt
10/29/1997	EP0803252A2 Treatment of central nervous system disorders with imidazole angiotensin-II receptor antagonists
10/29/1997	EP0802985A1 Cell cycle regulated repressor and dna element
10/29/1997	EP0802974A1 Neuron promoter and uses
10/29/1997	EP0802972A1 Nucleic acid encoding neuropeptide y/peptide yy (y2) receptors and uses thereof
10/29/1997	EP0802921A1 Human pak65
10/29/1997	EP0802914A1 Aryl and heteroaryl purine compounds
10/29/1997	EP0802912A1 Piperidine derivatives having tachykinin antagonist activity
10/29/1997	EP0802909A2 Substituted oxazolidine calpain and/or cathepsin b inhibitors
10/29/1997	EP0802908A1 Novel compounds
10/29/1997	EP0802902A1 Indole derivatives useful in the treatment of osteoporosis

1 ... 1608 1609 1610 1611 1612 1613 1614 1615 1616 1617 1618 1619 1620 1621 1622 1623 1624 1625 1626 1627 1628 ... 1833